Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: david nordic who wrote (31548)	3/29/2005 3:39:47 PM
From: fred hayes	Read Replies (2) \| Respond to of 32384

Thanks david. So the 3 percent is net after paying off RP. I was hoping for something like that, but my literal reading of the deals (still can't find the Ligand STEM royalties) made it look like ligand had completely sold out its interest. Only good news I've had all day... "Its not for sure." Boy oh boy, you don't have to remind me of that! (:>) By the way, wrt references to "low double digits on other compounds". Any chance these references are also net after the RP 3 percent rakeoff? TIA... fred hayes